HIK Hikma Pharmaceuticals Plc

 

TIDMHIK 
 
RNS Number : 4722U 
Hikma Pharmaceuticals Plc 
15 October 2010 
 

Block Listing of Shares 
 
                           Hikma Pharmaceuticals PLC 
 
 
 
LONDON, 15 October 2010 - The Board of Hikma Pharmaceuticals PLC ("Hikma") (LSE: 
HIK) (NASDAQ: HIK), announces that it has made a block listing application to 
the Financial Services Authority and the London Stock Exchange for a total of 
3,300,000 ordinary shares of 10p each in the capital of the Company to be 
admitted to the Official List of the UK Listing Authority.  It is expected that 
admission will be granted on 19 October 2010 and trading will commence on 20 
October 2010. 
 
The shares, when issued, will be issued fully paid and rank pari passu in all 
respects with the existing issued ordinary shares of the Company.  The shares 
will be issued pursuant to the vesting of shares under two option plans: 
1.     2,600,000 under the Hikma Pharmaceuticals PLC 2004 Stock Option Plan; and 
2.     700,000 under the Hikma Pharmaceuticals PLC 2005 Long Term Incentive Plan 
(together the "Plans"). 
 
Participants in the Plans have or will become entitled to these shares following 
the vesting of the shares. 
 
 
For further information, please contact: 
 
Henry Knowles, Company Secretary 
 Hikma Pharmaceuticals 
PLC 
+44 20 7399 2760 
 
Susan Ringdal, Investor Relations Director 
Hikma Pharmaceuticals PLC 
                      +44 20 7399 2760 
 
 
 
About Hikma 
Hikma Pharmaceuticals PLC is a fast growing multinational group focused on 
developing, manufacturing and marketing a broad range of both branded and 
non-branded generic and in-licensed  products.  Hikma's operations are conducted 
through three businesses: "Branded", "Injectables" and "Generics" based 
principally in the Middle East and North Africa ("MENA") region, where it is a 
market leader, the United States and Europe.  In 2009, Hikma achieved revenues 
of $637 million and profit attributable to shareholders of $78 million.  For 
news and other information, please visit www.hikma.com. 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 LISUVRRRRBARAAA 
 

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024